China Pharma Holdings (CPHI) Share-based Compensation Growth (3y) (2014 - 2026)
China Pharma Holdings (CPHI) Share-based Compensation Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184.67% |
| Dec 31, 2025 | 148.55% |
| Dec 31, 2024 | 1,549.67% |
| Dec 31, 2022 | 779.35% |
| Sep 30, 2022 | 334.50% |
| Jun 30, 2022 | 338.72% |
| Mar 31, 2022 | 8.32% |
| Mar 31, 2014 | 45.11% |